Garay R P, Nazaret C, Diez J, Etienne A, Bourgain R, Braquet P, Esanu A
Biochem Pharmacol. 1984 Jul 1;33(13):2013-20. doi: 10.1016/0006-2952(84)90567-7.
Two different families of diuretic drugs--(i) (aryloxy)acetic acid diuretics (ethacrynic acid, tienilic acid and (--)-indacrinone) and (ii) furopyridines [(+/-)-BN 50157 and (+/-)-cycletanide]--stimulate K+ movements across human red cell membranes. The kinetic properties of this effect (K+-specificity, saturability, optical isomerism, antagonism by structural analogues, etc.) strongly suggest that it is mediated by a K+-transport system with a specific binding site for some diuretic drugs. The stimulated K+ fluxes are resistant to ouabain, bumetanide and quinine, thus suggesting that they are not mediated by the Na+,K+-pump, Na+,K+-cotransport or by the Ca2+-dependent K+-permeability ('Gardos effect'). The replacement of Cl- by NO3- ions can either decrease, increase or have no effect on the stimulated K+ fluxes, depending on the diuretic drug. Although not conclusive, these observations suggest that the K+ fluxes are not mediated by stimulation of a chloride-dependent K+ carrier. The study of structural analogues showed that the intensity of the stimulation of K+ fluxes is strongly correlated with the magnitude of the natriuretic effect. Curiously, some antiallergic furopyridines are able to inhibit K+ fluxes.
两类不同的利尿药——(i)(芳氧基)乙酸类利尿药(依他尼酸、替尼酸和(-)-茚达立酮)和(ii)呋吡啶类[(±)-BN 50157和(±)-环戊噻嗪]——能刺激钾离子跨人红细胞膜的转运。这种效应的动力学特性(钾离子特异性、可饱和性、旋光异构性、结构类似物的拮抗作用等)强烈表明,它是由一种对某些利尿药具有特异性结合位点的钾离子转运系统介导的。所刺激的钾离子通量对哇巴因、布美他尼和奎宁具有抗性,因此表明它们不是由钠钾泵、钠钾协同转运或钙依赖性钾离子通透性(“加尔多斯效应”)介导的。用硝酸根离子替代氯离子,根据利尿药的不同,可使所刺激的钾离子通量降低、增加或无影响。尽管这些观察结果并非结论性的,但它们表明钾离子通量不是由刺激氯离子依赖性钾离子载体介导的。对结构类似物的研究表明,钾离子通量刺激强度与利钠效应的大小密切相关。奇怪的是,一些抗过敏呋吡啶类能够抑制钾离子通量。